Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results

Rhea-AI Summary

Bio-Techne (NASDAQ: TECH) has announced it will host a conference call and webcast on February 5, 2025, at 8:00 a.m. CST to discuss its second quarter fiscal 2025 financial results. Participants can join via phone by dialing 1-877-407-9208 (domestic) or 1-201-493-6784 (international) using Conference ID 13751305. The event will also be accessible through a webcast on the company's investor relations website.

For those unable to attend live, a recorded rebroadcast will be available from 11:00 a.m. CST on February 5 until 11:00 p.m. CST on March 5, 2025. The replay can be accessed by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international).

News Market Reaction

+3.85%

1 alert

+3.85% News Effect

On the day this news was published, TECH gained 3.85%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MINNEAPOLIS, Jan. 21, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, February 5, 2025, at 8:00 a.m. CST to review its second quarter fiscal 2025 financial results.

Access to the discussion may be obtained as follows:

Time:	8:00 a.m. CST
Date:	February 5, 2025
Dial-in:	1-877-407-9208 or 1-201-493-6784 (for international callers)
Conference ID:	13751305
Webcast:	https://investors.bio-techne.com/ir-calendar

A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 13751305.

The replay will be available from 11:00 a.m. CST on Wednesday, February 5, 2025, until 11:00 p.m. CST on Wednesday, March 5, 2025.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: Facebook, LinkedIn, Twitter or YouTube.

Contact:	David Clair, Vice President, Investor Relations & Corporate Development
	david.clair@bio-techne.com
	612-656-4416

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-february-5-2025-to-announce-second-quarter-fiscal-2025-financial-results-302354686.html

SOURCE Bio-Techne Corporation

FAQ

When will Bio-Techne (TECH) release its Q2 2025 earnings?

Bio-Techne will release its Q2 fiscal 2025 earnings on February 5, 2025, at 8:00 a.m. CST.

How can investors access Bio-Techne's Q2 2025 earnings call?

Investors can access the call by dialing 1-877-407-9208 (domestic) or 1-201-493-6784 (international) with Conference ID 13751305, or via webcast at the company's investor relations website.

How long will Bio-Techne's Q2 2025 earnings call replay be available?

The earnings call replay will be available from 11:00 a.m. CST on February 5 until 11:00 p.m. CST on March 5, 2025.

What is the replay dial-in number for Bio-Techne's Q2 2025 earnings call?

The replay can be accessed by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international) with Conference ID 13751305.